This site is intended for healthcare professionals
Journals
  • Home
  • /
  • Journals
  • /
  • Solid Organ Transplantation
  • /
  • Portal Flow Modulation in Living Donor Liver Trans...
Journal

Portal Flow Modulation in Living Donor Liver Transplantation: Review With a Focus on Splenectomy

Read time: 1 mins
Published:31st Dec 2019
Author: Yoshizumi T, Mori M.
Source: Surgery Today
Ref.:Surg Today. 2020;50(1):21‐29.
DOI:10.1007/s00595-019-01881-y

Small-for-size graft (SFSG) syndrome after living donor liver transplantation (LDLT) is the dysfunction of a small graft, characterized by coagulopathy, cholestasis, ascites, and encephalopathy. It is a serious complication of LDLT and usually triggered by excessive portal flow transmitted to the allograft in the postperfusion setting, resulting in sinusoidal congestion and hemorrhage. Portal overflow injures the liver directly through nutrient excess, endothelial activation, and sinusoidal shear stress, and indirectly through arterial vasoconstriction. These conditions may be attenuated with portal flow modulation. Attempts have been made to control excessive portal flow to the SFSG, including simultaneous splenectomy, splenic artery ligation, hemi-portocaval shunt, and pharmacological manipulation, with positive outcomes. Currently, a donor liver is considered a SFSG when the graft-to-recipient weight ratio is less than 0.8 or the ratio of the graft volume to the standard liver volume is less than 40%. A strategy for transplanting SFSG safely into recipients and avoiding extensive surgery in the living donor could effectively address the donor shortage. We review the literature and assess our current knowledge of and strategies for portal flow modulation in LDLT.


Read abstract on library site Access full article